Victor Mandia Moyo
Chief Medical Officer of OncologyDr. Victor Mandia Moyo, M.D., is Chief Medical Officer of Oncology of Traws Pharma, Inc. from April 12, 2024. Dr. Moyo was Consulting Chief Medical Officer of Traws Pharma, Inc. from August 2023 to April 12, 2024. Dr. Moyo joined the Traws Pharma, Inc. in June 2023. He served as Executive Vice President, Chief Medical Officer & Head of R&D at LEAF4Life LLC until February 2025. He served as Senior VP, Chief Medical Officer and Head of Research & Development of L.E.A.F. Pharmaceuticals LLC. He served as Consulting Chief Medical Officer of Traws Pharma, Inc. (formerly known as Onconova Therapeutics, Inc.) since August 2023 until April 12, 2024 and serves as its Chief Medical Officer of Oncology since April 12, 2024. He joined Onconova in August, 2023. He served as the Senior Consulting Medical Director of Diffusion Pharmaceuticals LLC until August 25, 2016. Dr. Moyo is an Oncologist/Hematologist with substantial experience in the development of novel therapeutic and companion diagnostic approaches to cancer. Prior to joining Diffusion Pharmaceuticals, he served as Vice President of Clinical Investigations at Merrimack Pharmaceuticals, providing clinical support for oncology programs including Pre-IND programs, First-in-Human, Phase 1 multi-arm safety and tolerability and Phase 2 proof of concept, studies involving multiple programs. he has also supported registration studies with the USFDA and other regulatory agencies. Prior to Merrimack Pharmaceuticals, his experience includes service as Medical Director for Centocor-Ortho Biotech (Johnson and Johnson) and service as an Assistant Professor in the Department of Medicine, Division of Hematology/ Oncology, University of Connecticut Medical Center, in Farmington CT. Dr. Moyo also has experience conducting clinical research in south and central Africa and has published on various other topics including iron overload disorders and malaria. He is also a co-inventor of several patents involving the treatment of several cancers. Dr. Moyo earned his M.D. from the University of Zimbabwe. He holds an MBChB degree from the School of Medicine, University of Zimbabwe and did internships at Mpilo Central Hospital, Bulawayo Zimbabwe and The George Washington University Medical Center, Washington, D.C. where he also completed his Residency in Internal Medicine. He also completed a fellowship in Hematology and Oncology at Johns Hopkins Hospital in Baltimore, MD.
Positions
- Company NameTraws Pharma, Inc.Stock CodeTRAWPositionChief Medical Officer of Oncology
